width= Osmotica Pharmaceutical receives FDA approval for Osmolex ER Extended-Release Tablets

Osmotica Pharmaceutical US LLC receives FDA approval Osmolex ER (amantadine hydrochloride) Extended-Release Tablets

Company: Osmotica Pharmaceutical US LLC

Brand Name: Osmolex ER

Generic Name: amantadine hydrochloride

Dosage Form: Extended-Release Tablets

Treatment for: Parkinson’s Disease, Extrapyramidal Reaction

 

General information about Osmolex ER

Osmolex ER (amantadine hydrochloride) is a proprietary formulation of immediate release and extended release amantadine for the once-a-day treatment of Parkinson’s disease and drug-induced extrapyramidal reactions.